Paul Hartmann AG (PHH2.F)
- Previous Close
212.00 - Open
208.00 - Bid 207.00 x 3200
- Ask 210.00 x 10000
- Day's Range
208.00 - 212.00 - 52 Week Range
178.50 - 244.00 - Volume
50 - Avg. Volume
110 - Market Cap (intraday)
738.762M - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
25.97 - EPS (TTM)
8.01 - Earnings Date Apr 26, 2024
- Forward Dividend & Yield 8.00 (3.85%)
- Ex-Dividend Date Apr 29, 2024
- 1y Target Est
--
Paul Hartmann AG manufactures and sells medical and care products in Germany, rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers disinfectant products for hands, surface, and instruments; cleaning, skin care, and skin antisepsis products, as well as Sterillium, a hand disinfectant; incontinence management products; and personal healthcare products, such as diagnostic devices and first aid products. The company also provides single-use and pre-surgical products, disposable surgical gloves, clothing and gowns, and disposable drapes for use in operating theatres, treatment rooms, and wards; and wound management solutions, including traditional compresses, bandages, hydro therapy products. In addition, it markets body care, dietary supplements, and herbal medicines under the brand name Happiness, that works; and sells private-label products in the field of cotton, cosmetic, medical, and baby and home care products. The company offers its products primarily through pharmacies, medical supply stores, online channels, and drugstores. The company was founded in 1818 and is headquartered in Heidenheim, Germany.
hartmann.info10,168
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: PHH2.F
Performance Overview: PHH2.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHH2.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHH2.F
Valuation Measures
Market Cap
738.76M
Enterprise Value
836.94M
Trailing P/E
26.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.31
Price/Book (mrq)
0.69
Enterprise Value/Revenue
0.36
Enterprise Value/EBITDA
4.99
Financial Highlights
Profitability and Income Statement
Profit Margin
1.20%
Return on Assets (ttm)
0.70%
Return on Equity (ttm)
2.92%
Revenue (ttm)
2.37B
Net Income Avi to Common (ttm)
28.42M
Diluted EPS (ttm)
8.01
Balance Sheet and Cash Flow
Total Cash (mrq)
145.13M
Total Debt/Equity (mrq)
22.93%
Levered Free Cash Flow (ttm)
92.13M
Company Insights: PHH2.F
PHH2.F does not have Company Insights